PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Biomarker detects graft-versus-host-disease in cancer patients after bone marrow transplant

Test may help rapid identification of severe graft-versus-host disease of the intestine in hematopoietic cell transplant patients with leukemia, lymphoma or other blood disorders

2011-10-22
(Press-News.org) A University of Michigan Health System-led team of researchers has found a biomarker they believe can help rapidly identify one of the most serious complications in patients with leukemia, lymphoma and other blood disorders who have received a transplant of new, blood-forming cells.

Known as a hematopoietic stem cell transplant, these patients receive bone marrow or peripheral blood stem cells from a matched donor who is either a family member or an unrelated volunteer.

The most common fatal complication of this type of transplant is graft-versus-host disease (GVHD), where the newly transplanted immune system of the donor attacks the patient's skin and internal organs. Up to 30 percent of recipients develop GVHD in their gastrointestinal tract, which is the organ most resistant to treatment.

Without invasive tests such as biopsies, however, GVHD can be difficult to distinguish from other causes of gastrointestinal distress, such as infection or side effects from medication.

The U-M team tested blood samples from over 1,000 patients who were treated in Ann Arbor, Germany and Japan.

"We believe we've found a reliable biomarker in the patients' blood that is specific to graft-versus-host disease and therefore can help us to rapidly identify patients for whom standard treatment is likely to be insufficient," says James L.M. Ferrara, M.D., co-lead author of the study and director of the U-M Combined Blood and Marrow Transplant Program. "This marker can also tell us whether a patient is likely to respond to therapy and may lead to an entirely new risk assessment for the disease. The findings were recently published online ahead of print publication in the journal Blood.

The marker, known as regenerating islet-derived 3-alpha (REG3-alpha), doesn't prevent patients from still needing a biopsy, Ferrara cautions, but taken with other predictive indicators, it could help doctors to ensure patients get the most appropriate treatment as early as possible.

Doctors at U-M hope to start using the test clinically in early 2012.

INFORMATION:

Funding: The research was supported by grants from the National Institutes of Health, Hartwell Foundation and Doris Duke Charitable Foundation.

Disclosure: The authors report no potential conflicts of interest. The University is presently looking for licensing partners to help bring the technology to market.

Additional U-M authors: Andrew C. Harris, M.D.; Joel K. Greenson, M.D.; Thomas M. Braun, Ph.D.; John E. Levine, M.D.; Sung W.J. Choi, M.D.; Mark Vander Lugt, M.D.; Pavan Reddy, M.D.; Sophie Paczesny, M.D.

For a full list of authors and to read the abstract of the paper, "Regenerating islet-derived 3 alpha is a biomarker of gastrointestinal graft-versus-host disease," visit: http://bit.ly/mR9daf

About the U-M Comprehensive Cancer Center:

The U-M Comprehensive Cancer Center is one of only 40 U.S. centers to earn the National Cancer Institute's "Comprehensive" designation by meeting strict guidelines for: Extensive, interactive and innovative clinical and laboratory research; participation in NCI testing of new therapies; significant cancer prevention and control research; provision of patient education, community service and outreach as well as training for health professionals.

The Cancer Center is also a founding member of the National Comprehensive Cancer Network, a consortium of 21 premiere cancer centers formed to develop national guidelines to ensure consistent, high-quality and cost-effective cancer care.

U-M Cancer AnswerLine, 800-865-1125
Clinical trials at U-M, www.UMClinicalStudies.org

Tweet: @UMHealthSystem
Facebook: www.facebook.com/UniversityofMichiganComprehensiveCancerCenter
Flickr: www.flickr.com/umhealthsystem
YouTube: www.youtube.com/umhealthsystem
Web: www.UofMHealth.org | www.mcancer.org
RSS: www.uofmhealth.org/news/rss

END



ELSE PRESS RELEASES FROM THIS DATE:

Elderly long-term care residents suffer cognitively during disasters

2011-10-22
In a summer with unprecedented weather events, from tornados, floods, fires and hurricanes, researchers at the University of Pennsylvania School of Nursing found that physiological changes associated with aging and the presence of chronic illness make older adults more susceptible to illness or injury, even death, during a disaster. Investigators followed 17 long-term care residents, with a mean age of 86, who were evacuated for five days due to a severe summer storm and were relocated to different facilities with different care providers and physical surroundings. The ...

Fluoride shuttle increases storage capacity

Fluoride shuttle increases storage capacity
2011-10-22
Lithium-ion batteries are applied widely, but their storage capacity is limited. In the future, battery systems of enhanced energy density will be needed for mobile applications in particular. Such batteries can store more energy at reduced weight. For this reason, KIT researchers are also conducting research into alternative systems. A completely new concept for secondary batteries based on metal fluorides was developed by Dr. Maximilian Fichtner, Head of the Energy Storage Systems Group, and Dr. Munnangi Anji Reddy at the KIT Institute of Nanotechnology (INT). Metal ...

Misdiagnosis of Stroke Persistent Problem Among Young Patients

2011-10-22
For those suffering a stroke, effective early treatment is critical in order to avoid long term complications or even death. But, stroke is commonly thought of as a condition only affecting older patients. According to a study presented at the American Stroke Association's International Stroke Conference, this misperception often leads to misdiagnosis when stroke victims seek medical attention in an emergency room setting. Nearly One in Seven Young Stroke Sufferers Misdiagnosed It is true that the typical stroke victim is at least 55 years old. However, research shows ...

Research involving thyroid hormone lays foundation for more targeted drug development

2011-10-22
Research led by St. Jude Children's Research Hospital scientists advances a strategy for taming the side effects and enhancing the therapeutic benefits of steroids and other medications that work by disrupting the activity of certain hormones. The approach relies on a small molecule developed at St. Jude. In this study, scientists showed that a compound known as SJ-AK selectively blocked the activity of genes in a cell signaling pathway regulated by thyroid hormone. Investigators showed that SJ-AK also affected cells growing in the laboratory, reducing cell proliferation ...

How do protein binding sites stay dry in water?

2011-10-22
In a report to be published soon in EPJE¹, researchers from the National University of the South in Bahía Blanca, Argentina studied the condition for model cavity and tunnel structures resembling the binding sites of proteins to stay dry without losing their ability to react, a prerequisite for proteins to establish stable interactions with other proteins in water. E.P. Schulz and colleagues used models of nanometric-scale hydrophobic cavities and tunnels to understand the influence of geometry on the ability of those structures to stay dry in solution. The authors ...

Human Error Leads to Medical Malpractice Suit in UPMC Kidney Transplant

2011-10-22
The University of Pittsburgh Medical Center (UPMC) is known as a leading American health care provider. Yet, despite UPMC's high ranking in hospital rating publications, serious medical errors can and do occur in its facilities. In early 2011, Michael Yocabet received a kidney from longtime girlfriend Christina Mecannic in an operation performed at UPMC Presbyterian. Although the surgery was completed without incident, it was later discovered that the donated kidney was infected with hepatitis C, which was passed to Yocabet. As a result, UPMC's living kidney donor transplant ...

Blood-pressure-lowering drug after stroke aids recovery, study finds

2011-10-22
Athens, Ga. – A commonly prescribed blood pressure-lowering medication appears to kick start recovery in the unaffected brain hemisphere after a stroke by boosting blood vessel growth, a new University of Georgia study has found. The discovery, based on a study using rats and published recently in the online journal PLoS ONE, occurred only because the team, led by Susan Fagan, professor of clinical and administrative pharmacy at the UGA College of Pharmacy, struck a new path in stroke research by examining the healthy side of brain after the stroke occurred. "I'm ...

Joint preservation in osteoarthritis

2011-10-22
Reconstructive surgical approaches can help delay endoprosthetic joint replacement in patients with osteoarthritis. Henning Madry and coauthors introduce such procedures in the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2011; 108[40]: 669-77). Articular cartilage defects often develop subsequent to injury or osteoarthritis. The authors in their article provide an overview of currently available medical and surgical therapeutic options. Medical therapy aims to preserve articular function for as long as possible and to delay surgical intervention. ...

Researchers generate first complete 3-D structures of bacterial chromosome

2011-10-22
WORCESTER, Mass. — A team of researchers at the University of Massachusetts Medical School, Harvard Medical School, Stanford University and the Prince Felipe Research Centre in Spain have deciphered the complete three-dimensional structure of the bacterium Caulobacter crescentus's chromosome. Analysis of the resulting structure —published this week in Molecular Cell — has revealed new insights into the function of genetic sequences responsible for the shape and structure of this genome. Scientists know that the three-dimensional shape of a cell's chromosome plays a role ...

What you want vs. how you get it

2011-10-22
New research reveals how we make decisions. Birds choosing between berry bushes and investors trading stocks are faced with the same fundamental challenge - making optimal choices in an environment featuring varying costs and benefits. A neuroeconomics study from the Montreal Neurological Institute and Hospital – The Neuro, McGill University, shows that the brain employs two separate regions and two distinct processes in valuing 'stimuli' i.e. 'goods' (for example, berry bushes), as opposed to valuing the 'actions,' needed to obtain the desired option (for example flight ...

LAST 30 PRESS RELEASES:

Research team receives $1.5 million to study neurological disorders linked to long COVID

Research using non-toxic bacteria to fight high-mortality cancers prepares for clinical trials

Do parents really have a favorite child? Here’s what new research says

Mussel bed surveyed before World War II still thriving

ACS Annual Report: Cancer mortality continues to drop despite rising incidence in women; rates of new diagnoses under 65 higher in women than men

Fewer skin ulcers in Werner syndrome patients treated with pioglitazone

Study finds surprising way that genetic mutation causes Huntington’s disease, transforming understanding of the disorder

DNA motors found to switch gears

Human ancestor thrived longer in harsher conditions than previous estimates

Evolution: Early humans adapted to extreme desert conditions over one million years ago

Race and ethnicity and diffusion of telemedicine in Medicaid for schizophrenia care after onset of the COVID-19 pandemic

Changes in support for advance provision and over-the-counter access to medication abortion

Protein level predicts immunotherapy response in bowel cancer

The staying power of bifocal contact lens benefits in young kids

Dose-dependent relationship between alcohol consumption and the risks of hepatitis b virus-associated cirrhosis and hepatocellular carcinoma: A meta-analysis and systematic review

International Alliance for Primary Immunodeficiency Societies selects Rockefeller University Press to publish new Journal of Human Immunity

Leader in mission-driven open publishing wins APE Award for Innovation in Scholarly Communication

Innovative 6D pose dataset sets new standard for robotic grasping performance

Evaluation of plasma neurodegenerative biomarkers for diagnosing minimal hepatic encephalopathy and predicting overt hepatic encephalopathy in Chinese patients with hepatic cirrhosis

MEXICO: How animals, people, and rituals created Teotihuacán

The role of political partisanship and moral beliefs in leadership selection

Parental favoritism isn't a myth

Arctic hotspots study reveals areas of climate stress in Northern Alaska, Siberia

Mount Sinai study finds wearable devices can detect and predict inflammatory bowel disease flare-ups

Peripheral blood CD4+/CD8+ t cell ratio predicts HBsAg clearance in inactive HBsAg carriers treated with peginterferon alpha

MIT Press’s Direct to Open reaches annual funding goal for 2025, opens access to 80 new monographs

New NCCN patient resource shares latest understanding of genetic testing to guide patient decision making

Synchronization in neural nets: Mathematical insight into neuron readout drives significant improvements in prediction accuracy

TLE6 identified as a protein associated with infertility in male mice

Thin lenses have a bright future

[Press-News.org] Biomarker detects graft-versus-host-disease in cancer patients after bone marrow transplant
Test may help rapid identification of severe graft-versus-host disease of the intestine in hematopoietic cell transplant patients with leukemia, lymphoma or other blood disorders